Loading candles…
Granules India Ltd, incorporated in 1991 and headquartered in Hyderabad, India, operates as a vertically integrated pharmaceutical company. It manufactures and sells Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, including core molecules such as Paracetamol, Metformin, Ibuprofen, Guaifenesin, and Methocarbamol. The company serves over 300 customers across more than 80 countries, primarily in the pharmaceutical industry. Granules India holds a significant market position in large-volume core molecules and utilizes high-capacity manufacturing to maintain cost leadership. There are no publicly reported subsidiaries, founders, key management details, or stock exchange listings associated with the company based on the available information.
This page is a live market overview for GRANULES INDIA LIMITED (GRANULES) on the NSE. As a listed security, GRANULES INDIA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GRANULES before placing trades on tick2trade.
As of the latest feed, GRANULES last traded at ₹873.85 on NSE, up ₹35.2 (4.20%) from the previous close of ₹838.65. Today's session range is ₹839.4 – ₹883, against a 52-week band of ₹432.6 – ₹910. Traded volume today stands at 11.47L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for GRANULES in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GRANULES is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GRANULES INDIA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GRANULES. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GRANULES option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 21 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 23 Jan 2026 |
| Fund Raising | To consider Fund Raising | 23 Dec 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend, if any. | 28 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.